1 Min Read
Oct 27 (Reuters) - Adamas Pharmaceuticals Inc
* Point72 Asset Management L.P reports a 5.1 percent passive stake in Adamas Pharmaceuticals Inc as of October 26, 2017 - SEC filing Source text : (bit.ly/2lnW6oI) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.